StockWatch
·
Biotechnology: Pharmaceutical Preparations
Management ChangeApr 6, 2026, 10:22 AM

Unicycive Therapeutics Director Gaurav Aggarwal Resigns

AI Summary

Gaurav Aggarwal, a director of Unicycive Therapeutics, Inc., resigned from the Board of Directors on April 6, 2026. The resignation was not due to any disagreement with the company's operations, policies, or practices. This change in board composition could be of interest to investors monitoring the company's leadership and governance.

Key Highlights

  • Gaurav Aggarwal resigned from Unicycive Therapeutics' Board of Directors.
  • The resignation was not due to any disagreement with the company.
  • The company expressed gratitude to Dr. Aggarwal for his service.